Southeast Asian generics market projected to grow
KUALA LUMPUR, Malaysia — A variety of macroeconomic factors are driving growth in the generic drug market in Southeast Asia.
According to CPhI, which is sponsoring the CPhI Southeast Asia Summit 2013 in Bangkok next month, the drug industry in the region is projected to grow to $3.9 billion by 2016, and macroeconomic factors, such as government policies, stable economies and growing population are driving generics.
"Generics will grow in the next five to 10 years, but without a balanced environment for cultivating innovation, such development will not be sustainable," Bayer Healthcare, China, senior patent attorney and conference speaker Jennifer Jian Kang said.
Government policies include plans by the Indonesian government to implement universal health coverage. "This is a huge undertaking by a government who, within the next four years, has targeted touching on over 90% of the population — a huge undertaking given Indonesia’s population of 240 million people," SOHO Group president, CEO and director Marcus Pitt said. "The pharmaceutical market dominated by local players has been gearing up its production and distribution infrastructure to cope with the expected multiple increases in generics."
The growth in generics, coupled with the fact that many governments in the region support local business, puts local generics manufacturers in a strong position. This means that most foreign companies will need to set up local partnerships, giving a welcome boost to local generics companies. - Penina Mezei, Attencia
L’Oréal Luxe Group launches makeup brand co-created by YouTube beauty vlogger, online community
NEW YORK — Em michelle phan, a start-up brand from the L’Oréal Luxe group, marks the first makeup line co-created by a community of beauty lovers and YouTube beauty vlogger Michelle Phan.
The line launched this month and is available at emcosmetics.com.
"Beauty lovers are increasingly consuming and sharing information digitally, through online communities. We saw the power of these communities and wanted to meet them where they live — online. Michelle Phan’s expertise in makeup, plus her passion for teaching and empowering women has made her a digital phenomenon. She represents exactly what this line is all about — community, empowerment, artistry," stated Carol Hamilton, president of L’Oréal Luxe.
Phan is self-taught and was one of the first beauty vloggers to produce story-driven makeup tutorials. The YouTube beauty guru began uploading tutorials in 2007. To-date, she has garnered nearly 1 billion views and has 4.5 million subscribers.
Em, a Vietnamese word meaning "you," is used affectionately to address loved ones including a little sister, girlfriend or elder. It is also literally and figuratively a reflection of "me" — it is a makeup line that reflects the needs of Phan’s community. The community has been a part of every piece of the brand, providing input on launch products, shade names and product packaging. Community members also appear in package design, brand photography and on the em michelle phan website.
At launch, em michelle phan will be sold exclusively online to U.S. customers at emcosmetics.com. Created to offer a social e-commerce experience, the site will allow beauty lovers to interact with friends and other consumers, provide feedback on creating looks and the products and share on their own social media channels. The makeup brand’s site is designed to enhance the digital shopping experience.
The em michelle phan line is comprised of more than 250 different SKUs. Hero products include:
- The Life Palette – Refillable eye shadow, cheek and lip palette with 36 shades each, themed around specific life moments and beauty stories including Love Life, Day Life, Beach Life, Career Life, Party Life and Night Life; priced at $75
- Artistic Cheek Color Palette available in 10 palettes; priced at $28
- Lip Color Mixing Palette available in six palettes; priced at $28
- Artistic Eye Color Palette available in 15 palettes; priced at $38
- The Great Cover Up – The ultimate creamy concealer in eight shades; priced at $19
- Makeup Mood Enhancer – Illuminating skin filter in five shades; priced at $25
- Pillow Plush – Cushiony lip balm in seven shades; priced at $15
- Chiaroscuro – Contour and highlighting stick in four shades; priced at $25
- Waterliner – Intense color eye liner in 12 shades; priced at $20
No comments found
CVS Caremark, Dovetail Health collaborate with Aetna in new pilot program
HARTFORD, Conn. and WOONSOCKET, R.I. — Aetna has announced a new pilot program, dubbed the Aetna Rx Home Success Program, which is supported by CVS Caremark.
The Aetna Rx Home Success Program works with CVS Caremark pharmacists and Dovetail Health to support Aetna members who are taking multiple medications. The program helps members manage their health through personal support from a pharmacist — including offering in-home consultations — and focuses on those who have recently been discharged from a hospital, nursing home or rehabilitation facility.
The six-month pilot program will be offered in the District of Columbia, Maryland and Northern Virginia. Readmission rates and member satisfaction of enrollees will be measured at the conclusion of the pilot.
How it works: Members who decide to enroll in the Aetna Rx Home Success Program are contacted by a pharmacist who will work with them to schedule an in-home visit or a detailed phone consultation. The pharmacist will review any new and/or pre-existing medications and help create a detailed care plan with the member and their doctor. The pharmacist will address potential medication-related issues, identify gaps in care and educate members about their medicine(s). The pharmacist also will consider other risk factors, including chronic conditions, home safety and will aid in arranging physician follow-up visits.
Hospital readmissions due to not properly taking their medication affect nearly 3.5 million patients and result in about $15.2 billion dollars in healthcare costs each year. Aetna’s approach to health care, blending the expertise of CVS Caremark and a Dovetail Health pharmacist, aims to provide a complete circle of care, ensuring positive health outcomes for its members.
"We look forward to piloting this program with Aetna as high rates of hospital readmissions result in increased costs for the patient and the payer, which can negatively impact a patient’s health outcomes," stated Troyen Brennan, EVP and chief medical officer for CVS Caremark. "Many patients who are newly discharged from a hospital or rehab facility are taking multiple medications. Trying to navigate multiple treatment guidelines provided by the patient’s primary care physician and the treatment facility discharge team can be overwhelming. Our research shows that the intervention of a clinical pharmacist helps patients better understand their medications and avoid potential setbacks to recovery after returning home."
Members are identified by an Aetna case manager as either "high risk" or "moderate risk" for hospital readmission. Within two days of discharge, high-risk members are contacted to schedule an in-home medication review performed by a Dovetail pharmacist. CVS Caremark pharmacists contact the moderate risk members to schedule a medication review over the phone. All members receive ongoing support in the form of follow-up phone calls for a 30-day period. Aetna case management nurses for continuing care coordination also mentor members. After the 30 days, the member will be discharged from the program and moved back to Aetna Case Management for continued follow-up and care.
No comments found